Immunotherapy for advanced penile cancer - rationale and potential
Nat Rev Urol
.
2018 Dec;15(12):721-723.
doi: 10.1038/s41585-018-0083-0.
Authors
Bradley McGregor
1
,
Guru Sonpavde
2
Affiliations
1
Genitourinary Oncology Division, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
2
Genitourinary Oncology Division, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
[email protected]
.
PMID:
30166593
DOI:
10.1038/s41585-018-0083-0
No abstract available
MeSH terms
Carcinoma, Squamous Cell / therapy*
Humans
Immunotherapy / methods*
Male
Papillomavirus Infections / complications
Penile Neoplasms / therapy*
Penile Neoplasms / virology